SCHEMBL25578967

SCHEMBL25578967

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2cccc(-c3ccc4ccccc4c3)c2)c2ccc3c(c2)oc2ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.34
▸ ANO1 Q5XXA6 1/20 0.32
▸ HSD17B1 P14061 2/20 0.32
▸ HSD17B2 P37059 2/20 0.32
▸ GPR84 Q9NQS5 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ MAPT P10636 2/20 0.31
▸ CYP1A1 P04798 2/20 0.31
▸ CYP1B1 Q16678 2/20 0.31
▸ AHR P35869 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ HPGD P15428 2/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ MEN1 O00255 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ THRB P10828 1/20 0.30
▸ RECQL P46063 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579518 0.96 HCRTR1 (0.35) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL25578900 0.96 ANO1 (0.34) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL25578886 0.96 ANO1 (0.34) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL25580375 0.94 HCRTR1 (0.33) HCRTR1HSD17B1HSD17B2GPR84ALDH1A1
SCHEMBL25578975 0.94 ANO1 (0.34) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL25578855 0.94 AHR (0.33) ALDH1A1MAPTAHRCYP1A2HPGD
SCHEMBL25579439 0.93 HCRTR1 (0.35) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL25579426 0.93 HCRTR1 (0.35) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL24919815 0.92 HCRTR1 (0.37) HCRTR1ANO1HSD17B1HSD17B2GPR84
SCHEMBL27274205 0.92 HCRTR1 (0.37) HCRTR1ANO1HSD17B1HSD17B2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 HCRTR1 3385/4885ANO1 324/4885HSD17B1 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback